Last updated: June 3, 2024
Sponsor: Universita degli Studi di Genova
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Diet
Clinical Study ID
NCT06448819
CDED-1
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- mild-to-moderate Crohn's disease activity (HBI between 5 and 16)
Exclusion
Exclusion Criteria:
- concomitant treatment with corticosteroids, antibiotic therapies and nutraceuticalsupplements, treatment with biological drugs and traditional immunosuppressantsstarted less than 24 weeks before enrollment, presence of active fistulas orabscesses, gastrointestinal tract surgery less than 6 months to randomization,coeliac disease, type 1 diabetes mellitus, uncontrolled type 2 diabetes mellitus,acute coronary disease (unstable angina, myocardial infarction), advanced acute orchronic liver disease, congestive heart failure (NYHA class III-IV), acute andchronic nephropathies (GRF<30 ml/min according to the CKD-EPI formula), presence ofacute infectious diseases and pregnancy.
Study Design
Total Participants: 45
Treatment Group(s): 1
Primary Treatment: Diet
Phase:
Study Start date:
January 20, 2023
Estimated Completion Date:
August 31, 2023
Connect with a study center
Giorgia Bodini
Genova, 16132
ItalySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.